INTERNATIONAL PATENT: SHANGHAI GENEPHARMA CO., LTD, 上海吉玛制药技术有限公司 FILES APPLICATION FOR "SIRNA AND MODIFIED SUBSTANCE THEREOF FOR INHIBITING DGAT2 AND USE THEREOF"

GENEVA, July 7 -- SHANGHAI GENEPHARMA CO., LTD (Building 2, No.368, Zhangjiang Road, Pudong New AreaShanghai 201210), 上海吉玛制药技术有限公司 (中国上海市浦东新区张江路368号2号楼) filed a patent application (PCT/CN2024/117522) for "SIRNA AND MODIFIED SUBSTANCE THEREOF FOR INHIBITING DGAT2, AND USE THEREOF" on Sep 06, 2024. With publication no. WO/2025/139037, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual...